TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35154550

Group type: EXPERIMENTAL
Intervention: Hydromorphone group (spinal anesthesia with 0.5% ropivacaine and 75 μg hydromorphone)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Morphine group (spinal anesthesia with 0.5% ropivacaine and 150 μg morphine)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Hydromorphone group
Number of subjects: 80

Group type: COMPARATOR
Intervention: Morphine group
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 33596734

Group type: EXPERIMENTAL
Intervention: intermittent theta burst stimulation (iTBS) applied to the injured (ACL) motor cortex leg representation (M1LEG)
Number of subjects: 20

Group type: COMPARATOR
Intervention: sham iTBS
Number of subjects: 20
Study: 33582693

Group type: COMPARATOR
Intervention: Standard Triple Drug Therapy
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Sequential Drug Therapy
Number of subjects: 62
Study: 37737025

Group type: EXPERIMENTAL
Intervention: Sintilimab regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observational management
Number of subjects: 0
Study: 34420177

Group type: EXPERIMENTAL
Intervention: Bioresorbable scaffolds (BRS)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Everolimus-eluting metallic stents (EES)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Bioresorbable scaffolds (BRS) in STEMI patients
Number of subjects: 103

Group type: COMPARATOR
Intervention: Everolimus-eluting metallic stents (EES) in STEMI patients
Number of subjects: 103
Study: 35108620

Group type: EXPERIMENTAL
Intervention: Brief hypnotic induction with reduced preoperative local anesthetics (Dave Elman technique)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Regular preoperative local anesthetics without brief hypnotic induction (standard care)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Brief hypnotic induction
Number of subjects: 33

Group type: COMPARATOR
Intervention: Standard care (regular local anesthetics)
Number of subjects: 33
Study: 34358827

Group type: COMPARATOR
Intervention: Leucine supplementation
Number of subjects: 200

Group type: COMPARATOR
Intervention: Whey supplementation
Number of subjects: 200

Group type: COMPARATOR
Intervention: Soy supplementation
Number of subjects: 200

Group type: COMPARATOR
Intervention: Creatine supplementation
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 200

Group type: COMPARATOR
Intervention: Whey supplementation (sex-based response)
Number of subjects: 200
Study: 35088725

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acustimulation (TEA)
Number of subjects: 50
Study: 34346662

Group type: EXPERIMENTAL
Intervention: Proton therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Model-based approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Epidemiological or real-life 'big data'
Number of subjects: 0
Study: 32573449

Group type: EXPERIMENTAL
Intervention: 3D imaging classification system
Number of subjects: 50
Study: 35839109

Group type: EXPERIMENTAL
Intervention: EBN intervention
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional perioperative care
Number of subjects: 72
Study: 33052555

Group type: EXPERIMENTAL
Intervention: Lanreotide 120 mg every 28 days
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo (for patients with progressive disease at the end of the core study)
Number of subjects: 89
Study: 36372250

Group type: EXPERIMENTAL
Intervention: Highly purified EPA (1800 mg/day)
Number of subjects: 2460

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2460
Study: 32584211

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Panic-Focused Psychodynamic Psychotherapy (PFPP)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Applied Relaxation Training (ART)
Number of subjects: 200
Study: 35348615

Group type: EXPERIMENTAL
Intervention: Nickel-titanium closed-coil springs (CS)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Elastomeric power chains (PC)
Number of subjects: 48
Study: 34644368

Group type: EXPERIMENTAL
Intervention: Very low carbohydrate diet (VLCBD) (<20g daily intake)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard low protein diet (LPD) (0.8g/kg/day)
Number of subjects: 30
Study: 32586077

Group type: COMPARATOR
Intervention: SQ‐PAP
Number of subjects: 17

Group type: COMPARATOR
Intervention: HT‐PAP
Number of subjects: 17
Study: 36038516

Group type: EXPERIMENTAL
Intervention: Multifunctional laser photoelectric platform combined with hydroxychloroquine (0.2 g, twice a day)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Hydroxychloroquine sulfate tablets (0.2 g, twice a day)
Number of subjects: 226
Study: 32092140

Group type: EXPERIMENTAL
Intervention: Andexanet alfa
Number of subjects: 0
Study: 35429850

Group type: EXPERIMENTAL
Intervention: Bilateral GNB with 0.125% bupivacaine, 0.5 xylocaine, and 4 mg dexamethasone
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group (Group 2)
Number of subjects: 400
Study: 34256820

Group type: EXPERIMENTAL
Intervention: Increased maternal speech exposure (treatment group, n = 21)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard medical care (control group, n = 21)
Number of subjects: 42
Study: 32543161

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide (2 ml, 0.25 mg/ml suspension for nebulizer) administered within 6 hours of birth and a second dose 12 hours later.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo inhalation (2 ml of distilled sterile water).
Number of subjects: 100
Study: 35232482

Group type: EXPERIMENTAL
Intervention: Multidisciplinary integrative care (IC)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Chiropractic care (CC)
Number of subjects: 201
Study: 34699407

Group type: EXPERIMENTAL
Intervention: 25% sucrose
Number of subjects: 85

Group type: COMPARATOR
Intervention: Water (placebo)
Number of subjects: 85
Study: 34194390

Group type: EXPERIMENTAL
Intervention: Ultrasound guided curettage with UAE
Number of subjects: 200

Group type: COMPARATOR
Intervention: Ultrasound guided curettage without UAE
Number of subjects: 200
Study: 33567942

Group type: EXPERIMENTAL
Intervention: Handshake Protocol (warm handoff approach)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard enrollment process (not explicitly detailed)
Number of subjects: 0
Study: 34518568

Group type: EXPERIMENTAL
Intervention: AI group (n=15) - performed 3 squat sets: 10 unassisted control squats, 10 squats with performance feedback from AI, and 10 additional unassisted test squats.
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PT group (n=15) - performed 3 identical sets, receiving performance feedback from PT.
Number of subjects: 30
Study: 35705944

Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 61
Study: 32595203

Group type: EXPERIMENTAL
Intervention: Blood culture
Number of subjects: 12000

Group type: EXPERIMENTAL
Intervention: Urine culture
Number of subjects: 12000
Study: 36198026

Group type: EXPERIMENTAL
Intervention: High baseline circulating tumor cells (CTCs) ≥ 5
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Higher CTC counts
Number of subjects: 103
Study: 34818400

Group type: EXPERIMENTAL
Intervention: CAF + L-PRF
Number of subjects: 34

Group type: COMPARATOR
Intervention: CAF + CTG
Number of subjects: 34
Study: 32790671

Group type: EXPERIMENTAL
Intervention: Intervention group (posters, lectures, distant electronic learning, reminders)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3
Study: 35206331

Group type: EXPERIMENTAL
Intervention: mhGAP training delivered by mental health specialists
Number of subjects: 205

Group type: COMPARATOR
Intervention: RESHAPE training delivered by specialists and people with lived experience of mental illness
Number of subjects: 205
Study: 34565424

Group type: EXPERIMENTAL
Intervention: Lateral episiotomy during vacuum-assisted delivery
Number of subjects: 23

Group type: COMPARATOR
Intervention: No episiotomy during vacuum-assisted delivery
Number of subjects: 23
Study: 36943681

Group type: EXPERIMENTAL
Intervention: EMME (eye movement modeling examples) group; 5-min ultrasound examination videos with expert's eye movements.
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group; identical videos without eye movements.
Number of subjects: 106
Study: 32943239

Group type: EXPERIMENTAL
Intervention: Genetically predicted an extra daily cup of tea consumption
Number of subjects: 349376
Study: 32669215

Group type: EXPERIMENTAL
Intervention: Puppet show during circumcision
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (no puppet show)
Number of subjects: 81
Study: 34921756

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg/day for 35 days
Number of subjects: 320

Group type: COMPARATOR
Intervention: No anticoagulation
Number of subjects: 320
Study: 32024551

Group type: EXPERIMENTAL
Intervention: Anterior quadratus lumborum block (QLB) using 0.25% levobupivacaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anterior quadratus lumborum block (QLB)
Number of subjects: 0
Study: 35443696

Group type: EXPERIMENTAL
Intervention: Accelerometer-measured physical activity (PA)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Maternal physical activity
Number of subjects: 106

Group type: COMPARATOR
Intervention: Child PA
Number of subjects: 106
Study: 33499679

Group type: EXPERIMENTAL
Intervention: Sugammadex calculated using corrected body weight (CBW), 4 mg/kg
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Sugammadex calculated using total body weight (TBW), 4 mg/kg
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group (not specified intervention)
Number of subjects: 125
Study: 33112758

Group type: EXPERIMENTAL
Intervention: Web conference systems for IRB meetings; 21 facilities implemented these systems.
Number of subjects: 31
Study: 35587284

Group type: EXPERIMENTAL
Intervention: semirigid extension-locked knee bracing for 8 days post-operatively
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no bracing)
Number of subjects: 72
Study: 34193056

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg/daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35166163

Group type: EXPERIMENTAL
Intervention: Positive face
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Negative face
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Neutral face
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (white screen)
Number of subjects: 38
Study: 33633195

Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 32
Study: 32108022

Group type: EXPERIMENTAL
Intervention: ACE inhibitors and statins (oral drugs)
Number of subjects: 443
Study: 36011510

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (50% VO2max)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: High-intensity exercise (80% VO2max)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Both groups (Moderate and High-intensity)
Number of subjects: 79
Study: 33562247

Group type: EXPERIMENTAL
Intervention: Bench-step exercise training (BSET)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 28
Study: 32485622

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 78
Study: 36013137

Group type: EXPERIMENTAL
Intervention: Gentle Touch Therapy (GTT)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 35259147

Group type: EXPERIMENTAL
Intervention: Active treatment (synchronized radiofrequency and HIFEM)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 72
Study: 33687872

Group type: EXPERIMENTAL
Intervention: Percutaneous left atrial appendage occlusion (LAAO) using Watchman, ACP, and Amulet devices
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long-term oral anticoagulation (OAC) with direct oral anticoagulants (DOACs)
Number of subjects: 0
Study: 32004567

Group type: EXPERIMENTAL
Intervention: Apremilast + NB-UVB
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo + NB-UVB
Number of subjects: 80
Study: 36419103

Group type: EXPERIMENTAL
Intervention: Comfort Young Child Formula (test group)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Comfort Young Child Formula (control group)
Number of subjects: 95
Study: 33599431

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (1000 mg daily for 8 weeks)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Medium chain triglyceride (1000 mg daily for 8 weeks)
Number of subjects: 54
Study: 34866304

Group type: EXPERIMENTAL
Intervention: ABC/3TC/DTG
Number of subjects: 91

Group type: COMPARATOR
Intervention: TDF/FTC/NNRTI
Number of subjects: 91
Study: 33818429

Group type: EXPERIMENTAL
Intervention: Torsion group III (min 240)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Torsion groups (I, II, III)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group IV (min 240)
Number of subjects: 28
Study: 33726523

Group type: EXPERIMENTAL
Intervention: intermittent theta burst stimulation (iTBS)
Number of subjects: 69

Group type: COMPARATOR
Intervention: continuous theta burst stimulation (cTBS)
Number of subjects: 69
Study: 33218559

Group type: EXPERIMENTAL
Intervention: Kinesio Taping combined with the motor relearning method (12 sessions)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Motor relearning method (12 sessions)
Number of subjects: 10
Study: 36135352

Group type: EXPERIMENTAL
Intervention: Zinc-hydroxyapatite-based paste applied on 2 MIH teeth in one random quadrant (test group)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (2 contralateral MIH teeth without paste application)
Number of subjects: 25
Study: 34053154

Group type: EXPERIMENTAL
Intervention: Uterine artery embolisation (UAE)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Myomectomy
Number of subjects: 254
Study: 32073408

Group type: EXPERIMENTAL
Intervention: Video-assisted CPR (V-CPR)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Telephone-assisted CPR (T-CPR)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Unassisted CPR (Control)
Number of subjects: 150
Study: 35489044

Group type: EXPERIMENTAL
Intervention: HABIT‐ILE training (90 hours over 2 weeks)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (customary treatment)
Number of subjects: 31
Study: 33581370

Group type: EXPERIMENTAL
Intervention: Social Support Index (assessed through support from mother, mother-in-law, husband, relatives)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Partner Support Index (assessed through husband's support)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Attention Shift Index (shift of attention from mother to baby)
Number of subjects: 240
Study: 34758069

Group type: EXPERIMENTAL
Intervention: Ibrutinib (420 mg daily)
Number of subjects: 363

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 363
Study: 34503367

Group type: EXPERIMENTAL
Intervention: IM20-4 (20μg, 4 doses)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: IM60-4 (60μg, 4 doses)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Short-term high-strength vaccination group (4 doses)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Standard vaccination group (3 doses)
Number of subjects: 303
Study: 36216035

Group type: EXPERIMENTAL
Intervention: Hand‐hold technique
Number of subjects: 316

Group type: COMPARATOR
Intervention: Lanyard technique
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Hand‐hold technique and Lanyard technique
Number of subjects: 316
Study: 33451954

Group type: EXPERIMENTAL
Intervention: Esmolol (1 mg/kg as a bolus before aortic cross‐clamping and 2 mg/kg mixed in the cardioplegia solution)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 200
Study: 616082720

Group type: EXPERIMENTAL
Intervention: Subretinal fluid aspiration
Number of subjects: 20

Group type: COMPARATOR
Intervention: Inverted ILM flap technique
Number of subjects: 20
Study: 36206005

Group type: EXPERIMENTAL
Intervention: ETC group (financial incentives for home dialysis use)
Number of subjects: 18621

Group type: COMPARATOR
Intervention: Control group (no financial incentives)
Number of subjects: 18621
Study: 34024186

Group type: EXPERIMENTAL
Intervention: Direct laryngoscopy using a McGrath videolaryngoscope
Number of subjects: 37

Group type: COMPARATOR
Intervention: Indirect laryngoscopy using a McGrath videolaryngoscope
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Both direct and indirect laryngoscopy using a McGrath videolaryngoscope
Number of subjects: 37
Study: 32138631

Group type: EXPERIMENTAL
Intervention: EG-1962 (600 mg intraventricular dose)
Number of subjects: 289

Group type: COMPARATOR
Intervention: Placebo (oral nimodipine)
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: EG-1962
Number of subjects: 289

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 289
Study: 34391812

Group type: EXPERIMENTAL
Intervention: 0.9% spinosad topical suspension
Number of subjects: 206

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 206
Study: 33179988

Group type: EXPERIMENTAL
Intervention: QSPR modelling of aliphatic compounds
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: QSPR modelling of phenyl‐based compounds
Number of subjects: 309
Study: 35894997

Group type: EXPERIMENTAL
Intervention: 1-second fast-speed eccentric resistance training
Number of subjects: 22

Group type: COMPARATOR
Intervention: 4-second slow-speed eccentric resistance training
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Overall increase in 1-repetition maximum
Number of subjects: 22
Study: 33975533

Group type: EXPERIMENTAL
Intervention: Women seeking abortion care
Number of subjects: 20
Study: 32755396

Group type: COMPARATOR
Intervention: Circumferential pulmonary vein isolation (CPVI) alone
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Additional electrical posterior box isolation (POBI)
Number of subjects: 114

Group type: COMPARATOR
Intervention: CPVI alone
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Additional POBI
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: POBI
Number of subjects: 114
Study: 35422053

Group type: EXPERIMENTAL
Intervention: Oral-transmucosal haloperidol 2.5 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Oral-transmucosal olanzapine 5 mg
Number of subjects: 80
Study: 33952548

Group type: EXPERIMENTAL
Intervention: Intervention involving an information pack for schools and access to a local paediatric ophthalmology clinic for up to 5% of participating children.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual practice (Control group).
Number of subjects: 0
Study: 32293657

Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT)
Number of subjects: 507

Group type: COMPARATOR
Intervention: Conventional wound treatment (CWT)
Number of subjects: 507
Study: 36056388

Group type: EXPERIMENTAL
Intervention: Personalised intervention programme including modules such as Brief messaging, Clinical medication review, Medication schedule, Reminding messaging, Medication dispensing systems, Smart messaging, Referral to general practitioner, Unguided web-based Self Help Application for low mood.
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Personalised intervention programme
Number of subjects: 300

Group type: COMPARATOR
Intervention: Usual care including access to a publicly available informative diabetes website.
Number of subjects: 300
Study: 33707410

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (weekly sessions from January 22 to March 11, 2020)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 22
Study: 35964417

Group type: EXPERIMENTAL
Intervention: Amphetamine (10 or 20 mg)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Modafinil (200 or 400 mg)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 106
Study: 33047488

Group type: EXPERIMENTAL
Intervention: Closed suction drainage (CSD)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Non-closed suction drainage (non-CSD)
Number of subjects: 160
Study: 35752926

Group type: EXPERIMENTAL
Intervention: Pilot complex care intervention
Number of subjects: 805
Study: 616357846

Group type: EXPERIMENTAL
Intervention: CCH plus vacuum plus modeling
Number of subjects: 30

Group type: COMPARATOR
Intervention: CCH plus vacuum only
Number of subjects: 30
Study: 35652531

Group type: EXPERIMENTAL
Intervention: Aprepitant-based anti-emetic regimen
Number of subjects: 0
Study: 34041719

Group type: COMPARATOR
Intervention: Sham ACB
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Ropivacaine ACB
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Ropivacaine ACB with MgSO4
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: All groups (sham, ropivacaine ACB, ropivacaine ACB with MgSO4)
Number of subjects: 121
Study: 32068285

Group type: EXPERIMENTAL
Intervention: Web-based therapeutic education intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 32496448

Group type: EXPERIMENTAL
Intervention: Goal-directed therapy (gDT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 40
Study: 34836275

Group type: EXPERIMENTAL
Intervention: Vinegar group (1.5 g acetic acid/day as liquid vinegar)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (0.015 g acetic acid/day as a pill)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Vinegar ingestion
Number of subjects: 25
Study: 32697555

Group type: EXPERIMENTAL
Intervention: Defocus + AA92593 group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Defocus group
Number of subjects: 20
Study: 33562216

Group type: EXPERIMENTAL
Intervention: Dietitian-directed groceries (DDG)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Self-directed grocery shopping (SDG)
Number of subjects: 43
Study: 35385090

Group type: EXPERIMENTAL
Intervention: PARS intervention (1-session secondary prevention module administered by trained SUD counselors)
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: PARS intervention
Number of subjects: 906

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 906
Study: 33564993

Group type: EXPERIMENTAL
Intervention: Intrathecal bupivacaine and morphine (ITBM) group, n = 45
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intrathecal bupivacaine (ITB) group, n = 42
Number of subjects: 100